Wells Fargo maintains Underweight on WR Berkley, raises target to $68
Wells Fargo analyst Elyse Greenspan maintained an Underweight rating on WR Berkley and raised the price target to $68 from $67, indicating a revised valuation outlook. This contrasts with Truist Securities' Buy rating and higher price target of $83.

*this image is generated using AI for illustrative purposes only.
Wells Fargo analyst Elyse Greenspan maintained an Underweight rating on WR Berkley (NYSE: WRB) while raising the price target to $68 from $67. The adjustment reflects a revised valuation outlook despite the cautious stance on the insurance holding company's performance potential.
Rating and Price Target
The research note updates the investment thesis on WR Berkley, retaining the Underweight recommendation. The price target increase of $1 suggests a modest upside potential based on the firm's analysis.
| Metric | Value |
|---|---|
| Rating | Underweight |
| Previous Price Target | $67 |
| New Price Target | $68 |
The revised target provides investors with a new benchmark for the stock's performance expectations. This update follows a previous rating from Truist Securities analyst Mark Hughes, who maintained a Buy rating with a price target of $83.
What specific valuation metrics drove the $1 price target increase despite the maintained Underweight rating?
How might WR Berkley's upcoming earnings report influence other analysts to align with either Wells Fargo's cautious stance or Truist's more bullish outlook?
What market conditions or sector trends could prompt Wells Fargo to upgrade the stock from Underweight in the future?

































